COSENTIX Trademark

Trademark Overview

On Tuesday, February 5, 2013, a trademark application was filed for COSENTIX with the United States Patent and Trademark Office. The USPTO has given the COSENTIX trademark a serial number of 79127647. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, December 4, 2022. This trademark is owned by NOVARTIS AG. The COSENTIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
cosentix

General Information

Serial Number79127647
Word MarkCOSENTIX
Filing DateTuesday, February 5, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, December 4, 2022
Registration Number4427248
Registration DateTuesday, November 5, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Sunday, July 2, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, July 2, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, February 19, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, January 22, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, January 22, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Monday, November 5, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, March 1, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 7, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 7, 2014FINAL DISPOSITION PROCESSED
Wednesday, February 5, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 5, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, August 20, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 20, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 31, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 16, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 15, 2013ASSIGNED TO LIE
Wednesday, June 26, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 26, 2013EXAMINER'S AMENDMENT ENTERED
Wednesday, June 26, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 26, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, June 26, 2013EXAMINERS AMENDMENT -WRITTEN
Sunday, May 26, 2013REFUSAL PROCESSED BY IB
Wednesday, May 22, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 22, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 7, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 7, 2013REFUSAL PROCESSED BY MPU
Tuesday, May 7, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, May 6, 2013NON-FINAL ACTION WRITTEN
Friday, April 26, 2013ASSIGNED TO EXAMINER
Tuesday, April 16, 2013APPLICATION FILING RECEIPT MAILED
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Thursday, April 11, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 9, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 4, 2013SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

cosentix disorders system preparations pharmaceutical diseases treatment prevention caused bacteria ophthalmology